Subscribe To
ADGI / ADGI Stock Alert: The Omicron Variant Just Sent Adagio Therapeutics Plunging
ADGI News
By 24/7 Wall Street
August 22, 2022
Hedge Fund M28 Capital Increases Adagio Therapeutics (ADGI) Stake to 8.5%
Last Friday, health care focused hedge fund M28 Capital filed a 13D/A with the US Securities & Exchange Committee revealing it bought 2.85 million Ad more_horizontal
By Benzinga
March 30, 2022
Why Adagio Therapeutics Stock Is Soaring Today
Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the more_horizontal
By Seeking Alpha
February 16, 2022
Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention
Three recent independent in-vitro studies show that ADG20 has neutralization activity against Omicron. more_horizontal
By Seeking Alpha
February 16, 2022
Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention
Three recent independent in-vitro studies show that ADG20 has neutralization activity against Omicron. more_horizontal
By Seeking Alpha
February 16, 2022
Adagio: A COVID-19 Play With Big Potential On Possible Treatment And Prevention
Three recent independent in-vitro studies show that ADG20 has neutralization activity against Omicron. more_horizontal
By The Motley Fool
January 20, 2022
Why Shares of Adagio Therapeutics Soared 25.9% on Thursday
The clinical-stage biotech company is working on an antiviral treatment to fight multiple variants of COVID-19. more_horizontal
By The Motley Fool
January 20, 2022
Why Shares of Adagio Therapeutics Soared 25.9% on Thursday
The clinical-stage biotech company is working on an antiviral treatment to fight multiple variants of COVID-19. more_horizontal
By The Motley Fool
January 20, 2022
Why Shares of Adagio Therapeutics Soared 25.9% on Thursday
The clinical-stage biotech company is working on an antiviral treatment to fight multiple variants of COVID-19. more_horizontal